-
Estimating the Broader Societal Impact of Ocrelizumab for Multiple Sclerosis (MS) in Latin America (LATAM) Using a Social Impact Approach
Sep 9, 2025, 16:22 PM -
EU HTA JCA PICO Consolidation Process Examples: Key Trends and Remaining Uncertainties
Sep 9, 2025, 16:22 PM -
Knowledge and Awareness of Primary Care Physicians (PCPs) Towards Respiratory Syncytial Virus (RSV) in Australia, Hong Kong, Japan, New Zealand, South Korea, Singapore, and Taiwan
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab Plus Chemotherapy in the First-Line Treatment for Metastatic Triple-Negative Breast Cancer (TNBC) in Türkiye
Sep 9, 2025, 16:22 PM -
Prevalence of Post-Traumatic Stress Disorder Among Ambulance Officers During the COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
Literature Review on the Economic Impact of Maternal Fetal Infections
Sep 9, 2025, 16:22 PM -
A Disease Progression Model Comparing Respiratory and Motor Decline in People With Late-Onset Pompe Disease Treated With Cipaglucosidase Alfa Plus Miglustat vs. Alglucosidase Alfa
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Impact of Worksite Physical Activity Interventions in Denmark: An Employer’s Perspective
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use Among Children With Mucopolysaccharidosis Type III MPS III: A Retrospective Claims Database Analysis in the US
Sep 9, 2025, 16:22 PM -
Ai-Augmented Data Extraction in Literature Reviews: Toward First-Pass Accuracy Competitive With Human Performance
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Impact of the COVID-19 Pandemic on Healthcare Expenditure
Sep 9, 2025, 16:22 PM -
(HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)
Sep 9, 2025, 16:22 PM -
Incorporating Environmental Impact Into Health Economic Evaluations: A Review of Methodological Approaches and Practical Applications
Sep 9, 2025, 16:22 PM -
Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in France: A Use Case in Rare Diseases
Sep 9, 2025, 16:22 PM -
Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Illness Among High-Risk Adults Aged 18-59 Years in Germany
Sep 9, 2025, 16:22 PM -
Examining the Opportunity Costs Due to Diabetic Macular Edema Taking Into Account Access Barriers Evaluated in the Barometer Program Survey in Colombia
Sep 9, 2025, 16:22 PM -
Correlation Between Extension Survival Benefits and Incremental Costs of Oncology Drugs in Portugal: A Cross-Sectional, Regression Analysis
Sep 9, 2025, 16:22 PM -
Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk
Sep 9, 2025, 16:22 PM -
Estimating Life-Years and QALYs Gained From Tumor Treating Fields in Newly Diagnosed Glioblastoma: A US-Based Real-World Survival-Based Model
Sep 9, 2025, 16:22 PM
